Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis drugs: Sticker shock.
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.
Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation.
[Vitamin d, determinant of bone and extrabone health . Import ance of vitamin d supplementation in milk and dairy products].
Engagement in a program promoting lifestyle modification is associated with better patient-reported outcomes for people with MS.
Correction: The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case study.
Cerebral venous thrombosis after high dose steroid in multiple sclerosis: a case report.
Acute demyelinating encephalomyelitis presenting with psychiatric symptoms.
Sodium channel blockers for neuroprotection in multiple sclerosis.
Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open.
Perception of muscular effort during dynamic elbow extension in multiple sclerosis.
Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide.
Electrodiagnostics and clinical correlates in acquired polyneuropathies.
Chronic Inflammatory Pure Sensory Polyradiculoneuropathy: A Rare CIDP Variant With Unusual Electrophysiology.
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their management.
Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields.
Fatigue in Multiple Sclerosis Compared to Stroke.
Haplotype-based approach to known MS-associated regions increases the amount of explained risk.
Environmental Enrichment Stimulates Immune Cell Secretion of Exosomes that Promote CNS Myelination and May Regulate Inflammation.
Vestibular and ocular motor function prior to and after therapeutic apheresis with small plasmafilter in multiple sclerosis.
Ultraviolet radiation, vitamin D and multiple sclerosis.
Natalizumab Use In Multiple Sclerosis: A Real World Evidence (Rwe) Analysis of Its Impact on Nhs Resources In England.
Pages
« first
‹ previous
…
680
681
682
683
684
685
686
687
688
…
next ›
last »